Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.
The prospective study involved 2,400 non-expert participants. Assistance from a GPT-4o-based chatbot integrated within a WeChat environment improved accuracy in diagnosing respiratory conditions across 88 clinical vignettes.
Read the original →NVIDIA Inception companies are applying AI to each stage of the breast cancer care journey. These stages are imaging, risk assessment and treatment decisions.
Read the original →Recent advances in AI have changed how electrocardiography (ECG) is applied in cardiovascular diagnostics. The AI-ECG analysis market is expected to grow from $2.01 billion in 2025 to $2.40 billion in 2026, a compound annual growth rate of 19.3%.
Read the original →Nearly 1.5 million new cases of skin cancer were diagnosed in 2024, according to World Health Organization data. The University of Alicante and the Sant Joan d'Alacant University Hospital collaborated to launch MEL-IA (MobilE skin Lesion dIAgnosis). The AI system is designed to automate the classification of skin lesions.
Read the original →Teladoc Health launched Teladoc One in July 2026, introducing an integrated virtual care model supported by always-on AI. It is built on more than 100 million virtual visits across primary care, mental health, chronic illness and acute care.
Read the original →A Korean-led study tested B-RAD across 8,311 ultrasound images. Its strongest result came from 289 retrospective cases, not from a patient-outcomes trial.
Read the original →The $25 million Texas governance programme highlights that NHS trusts adopting AI have no comparable register, monitoring duty or learning system.
Read the original →AI-driven fraud is surging worldwide as criminals exploit voice cloning and document forgery. These methods are outpacing traditional security measures.
Read the original →In November, clinical operations professionals will gather at the OCT DACH meeting. They will discuss challenges reshaping clinical trials.
Read the original →AbbVie and Iambic have launched a multi-year collaboration using AI to accelerate small-molecule drug discovery. The work spans immunology, neuroscience and oncology.
Read the original →The Center of Excellence in Cybersecurity Research, Education and Outreach is marking Cybersecurity Awareness Month with a speaker series. The series runs through Oct. 29.
Read the original →Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Read the original →AIRS Medical said on October 5, 2026, that the U.S. Food and Drug Administration granted 510(k) clearance for SwiftSight Body Composition, its AI-powered quantitative MRI software. SimonMed Imaging is the first customer.
Read the original →Generative AI is gaining traction across the Medical Instruments industry as companies move from experimentation to practical applications. The technology is being used to generate synthetic medical images, simulate disease progression, and create potential drug molecules and predict their effects.
Read the original →Deep Health AI India Ltd approved acquiring debt worth ₹10,35,35,520 from Kshitij Polyline Limited. The deal includes the benefit of a pledge over 4,900 equity shares (49%) in Sparion Infrastructure Private Limited. The transaction is structured on a "without recourse" basis and is not a related party transaction.
Read the original →Generative and interactive artificial intelligence is making its presence felt across society. Experts say they are worried about its expanding presence in the lives of overly trusting teens.
Read the original →A 93,326-scan NHS trial found that AI worklist prioritisation cut X-ray reporting time. It did not speed up CT scans, diagnosis, treatment or cancer stage.
Read the original →The author describes spending years trying to turn complex patient histories, test results, symptoms, medications, supplements and past treatments into a coherent clinical plan. In complex cases, this could take up to three hours of research. The author's first reaction to the arrival of generative AI was relief.
Read the original →